GlaxoSmithKline Intellectual Property Development Limited
发明人:
Berger, Scott B.,Gough, Peter J.,Weisel, Kathleen M.
申请号：
AU2015304851
公开号：
AU2015304851A1
申请日:
2015.08.20
申请国别(地区):
AU
年份:
2017
代理人:
摘要：
Disclosed is a method of treating a RIP1 kinase-mediated disease or disorder which comprises administering a therapeutically effective amount of a compound that inhibits RIP1 kinase and at least one other therapeutically active agent to a patient in need thereof.
